Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 1/2 2Phase 1 2

Status

Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Genitourinary 1Dermatologic 1

Conditions

Glioblastoma 2Glioma 1Brain Neoplasms 1

Interventions

Temozolomide 102Radiotherapy 47Bevacizumab 33Carboplatin 23Irinotecan 20pembrolizumab 17Radiosurgery 16Nivolumab 16Radiation 14Cyclophosphamide 11Magnetic Resonance Spectroscopy 10fludarabine 8Trastuzumab 8Radiotherapy, Intensity-Modulated 8Carmustine 8Surgical Procedures, Operative 7Specimen Handling 7Pemetrexed 7Paclitaxel 7Interleukin-2 7Filgrastim 7Everolimus 7Erlotinib Hydrochloride 7temsirolimus 6Vorinostat 6Radiotherapy, Conformal 6Lomustine 6Ipilimumab 6Granulocyte-Macrophage Colony-Stimulating Factor 6Gemcitabine 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Diet, Ketogenic × CNS × Clear all
NCT02046187 2021-06-16

Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma

St. Joseph's Hospital and Medical Center, Phoenix

Phase 1/2 Terminated
14 enrolled
CNS

Brain Neoplasms, Glioblastoma, Glioma

NCT02939378 2016-10-20

KGDinrGBM

Beijing Tiantan Hospital

Phase 1/2 Unknown
60 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡